Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antimicrobial Resistance
100%
Bacterial Antibiotic Resistance
100%
WHO European Region
100%
Drug Combination
40%
Escherichia Coli
20%
Bacterial Pathogens
20%
Public Health
20%
Uncertainty Interval
20%
Healthcare
10%
Descending Order
10%
Streptococcus Pneumoniae
10%
Staphylococcus Aureus
10%
Outcomes Research
10%
High Mortality Rate
10%
Pseudomonas Aeruginosa (P. aeruginosa)
10%
Social Care
10%
Predictive Validity
10%
Modern Healthcare
10%
Antimicrobial
10%
Klebsiella Pneumoniae (K. pneumoniae)
10%
Multidrug-resistant Pathogens
10%
Wellcome Trust
10%
Downstream Effects
10%
Health Departments
10%
Resistance Level
10%
Cross-country Analysis
10%
Number of Deaths
10%
Laboratory Technology
10%
Health Impact
10%
Mortality Risk
10%
Medical Technology
10%
Continuous Outcomes
10%
Methicillin-resistant S. Aureus
10%
Disease Burden
10%
Global Stakeholders
10%
Disability-adjusted Life Years
10%
Technology Companies
10%
Bill & Melinda Gates Foundation
10%
Human Mortality
10%
Respiratory Infection
10%
Excess Risk
10%
Bloodstream Infection
10%
Enterococcus Faecium
10%
Private Laboratory
10%
Aminopenicillin
10%
Research Hospital
10%
Counterfactual Scenarios
10%
Intra-abdominal Infection
10%
Acinetobacter Baumannii (A. baumannii)
10%
Hospital Surveillance
10%
Multidrug-resistant Infection
10%
Surveillance Network
10%
Medicine and Dentistry
Antibiotic Resistance
100%
Pathogen
92%
Infection
38%
Combination Drug
30%
Public Health
23%
Escherichia coli
15%
Staphylococcus aureus
15%
Antiinfective Agent
7%
Antimicrobial Agent
7%
Health Care
7%
Mortality Rate
7%
Pseudomonas aeruginosa
7%
Klebsiella pneumoniae
7%
Meticillin
7%
Pneumococcal Pneumonia
7%
Streptococcus pneumonia
7%
Medical Technology
7%
Acinetobacter Baumannii
7%
Disability Adjusted Life Years
7%
Respiratory Tract Infection
7%
Disease Burden
7%
Amoxicillin Plus Clavulanic Acid
7%
Aminopenicillin
7%
Bloodstream Infection
7%
Abdominal Infection
7%
Enterococcus faecium
7%
Nursing and Health Professions
World Health Organization
100%
Antibiotic Resistance
100%
Infection
38%
Combination Drug
30%
Public Health
15%
Syndrome
15%
Health Care
7%
Antimicrobial Agent
7%
Antiinfective Agent
7%
Predictive Validity
7%
Mortality Rate
7%
Medical Technology
7%
Disease Burden
7%
Respiratory Tract Infection
7%
Disability-Adjusted Life Year
7%
Amoxicillin Plus Clavulanic Acid
7%
Aminopenicillin
7%
Meticillin
7%
Bloodstream Infection
7%
Streptococcus pneumonia
7%
Pseudomonas Pneumonia
7%
Abdominal Infection
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
100%
Infectious Agent
92%
Infection
38%
Combination Drug
30%
Escherichia coli
15%
Staphylococcus aureus
15%
Syndrome
15%
Antimicrobial Agent
7%
Antiinfective Agent
7%
Diseases
7%
Streptococcus pneumonia
7%
Pseudomonas aeruginosa
7%
Klebsiella pneumoniae
7%
Meticillin
7%
Mortality Rate
7%
Acinetobacter Baumannii
7%
Amoxicillin Plus Clavulanic Acid
7%
Respiratory Tract Infection
7%
Bloodstream Infection
7%
Aminopenicillin
7%
Abdominal Infection
7%
Enterococcus faecium
7%
Immunology and Microbiology
Antibiotic Resistance
100%
Infectious Agent
92%
Infection
61%
Escherichia coli
15%
Staphylococcus aureus
15%
Antimicrobial Agent
7%
Streptococcus pneumonia
7%
Pseudomonas aeruginosa
7%
Klebsiella pneumoniae
7%
Acinetobacter Baumannii
7%
Mortality Rate
7%
Disease Burden
7%
Enterococcus faecium
7%
Disability-Adjusted Life Year
7%